0001225208-11-012073.txt : 20110421
0001225208-11-012073.hdr.sgml : 20110421
20110421104015
ACCESSION NUMBER: 0001225208-11-012073
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20110420
FILED AS OF DATE: 20110421
DATE AS OF CHANGE: 20110421
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: HUMAN GENOME SCIENCES INC
CENTRAL INDEX KEY: 0000901219
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 223178468
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 14200 SHADY GROVE ROAD
CITY: ROCKVILLE
STATE: MD
ZIP: 20850-3338
BUSINESS PHONE: 3013098504
MAIL ADDRESS:
STREET 1: 14200 SHADY GROVE ROAD
CITY: ROCKVILLE
STATE: MD
ZIP: 20850
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Bateson Susan D.
CENTRAL INDEX KEY: 0001191234
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-14169
FILM NUMBER: 11772386
MAIL ADDRESS:
STREET 1: 14200 SHADY GROVE ROAD
CITY: ROCKVILLE
STATE: MD
ZIP: 20850
FORMER NAME:
FORMER CONFORMED NAME: MCKAY SUSAN D BATESON
DATE OF NAME CHANGE: 20020920
4
1
doc4.xml
X0303
4
2011-04-20
0000901219
HUMAN GENOME SCIENCES INC
HGSI
0001191234
Bateson Susan D.
14200 SHADY GROVE ROAD
ROCKVILLE
MD
20850
1
Senior Vice President
Common Stock
2011-04-20
4
M
0
24000.0000
0.5200
A
89270.0000
D
Common Stock
2011-04-20
4
S
0
24000.0000
28.7499
D
65270.0000
D
Employee Stock Option - Right to Buy
0.5200
2011-04-20
4
M
0
24000.0000
0.0000
D
2019-03-10
Common Stock
24000.0000
67997.0000
D
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person and Charles Schwab effective 3/18/11.
This transaction was executed in multiple trades at prices ranging from $28.09 to $28.94. The price reported above reflects the weighted average sale price. Upon written request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price is available.
One eighth of the options granted vested on September 10, 2009, the six-month anniversary date of the grant, and the remaining options granted vested and continue to vest monthly on a ratable basis for the next 42 months commencing on October 10, 2009.
/s/ Susan D. Bateson
2011-04-21